UBS Downgrades Ironwood Pharmaceuticals (IRWD) to Sell

January 16, 2013 7:10 AM EST Send to a Friend
Get Alerts IRWD Hot Sheet
Price: $15.00 +2.25%

Rating Summary:
    8 Buy, 9 Hold, 3 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 42 | New: 52
Trade IRWD Now!
Join SI Premium – FREE
UBS downgraded Ironwood Pharmaceuticals (NASDAQ: IRWD) from Neutral to Sell.

For an analyst ratings summary and ratings history on Ironwood Pharmaceuticals click here. For more ratings news on Ironwood Pharmaceuticals click here.

Shares of Ironwood Pharmaceuticals closed at $14.69 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

UBS

Add Your Comment